Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Treatment of Acute Heart Failure

Tume, Sebastian C. MD; Schwartz, Steven M. MD, FRCPC; Bronicki, Ronald A. MD, FCCM, FACC

doi: 10.1097/PCC.0000000000000635
Supplement
Buy

Objectives: To provide an evidence-based review of pharmacotherapies to treat acute heart failure. To accomplish this objective, we will discuss circulatory physiology, vasoactive agents, and their indications in the management of acute heart failure.

Data Source: A MEDLINE-baseline review of the literature.

Conclusions: The optimal selection of vasoactive agents requires a consideration of circulatory physiology and the tailored application of pharmacotherapies to treat patients with acute heart failure.

1Department of Pediatrics, Baylor College of Medicine, Sections of Critical Care Medicine and Cardiology, Texas Children’s Hospital, Houston, TX.

2Departments of Pediatrics and Critical Care Medicine, University of Toronto, the Hospital of Sick Children, Toronto, ON, Canada.

The authors have disclosed that they do not have any potential conflicts of interest.

For information regarding this article, E-mail: sctume@texaschildrens.org

©2016The Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies